Press release
Parkinson's Disease Drug Market Trends, Research Report, Growth, Opportunities, Forecast 2022-2028
The Global Parkinson's disease market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Pharmaceutical firms are developing new and improved therapies for Parkinson's disease (PD). Recently, there have been some major product launches in Parkinson's disease. For instance, in February 2022, Avion Pharmaceuticals LLC announced the commercial launch of DHIVY, the first and only carbidopa/ levodopa (CD/LD) fractional tablet designed to be divided. Avion gained approval for DHIVY from the FDA in Nov 2021. This unique design enables more precise medication for those with Parkinson's disease (PD). Also, government funding for research and massive utilization of L-Dopa, asymptomatic dopamine replacement treatment, and the nigrostriatal system expects a boost to the market in the coming years.A full report of Parkinson's Disease Drug Market is available at: https://www.omrglobal.com/industry-reports/parkinsons-disease-drug
The shifting of research activities from symptomatic treatment to Parkinson's disorder modifying treatment will create growth for Parkinson's disease treatment industry over the forthcoming years. For instance, Kyowa Kirin Co Ltd a Japanese Pharmaceutical and biotechnology company announced the U.S. Food and Drug Administration (FDA) approval for medicine NOURIANZ (istradefylline). For instance, in Feb 2020, Sun Pharma launched severe nodular acne management capsules in the US. It is launched for patients who are below 12 years of age or older. It can be taken with or without food.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/parkinsons-disease-drug
Market Coverage
• The market number available for - 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered- By Mechanism of Action
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Land- AbbVie Inc., Merck & Co. Inc., Boehringer Ingelheim GmbH, GlaxoSmithKline Plc, Bausch Health Companies Inc., Cipla Inc., Daiichi Sankyo Espha Co., Ltd., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impact the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Parkison's Disease Drug Market Report Segment
By Mechanism of Action
• Dopamine Agonists
• Anticholinergic
• MAO-B Inhibitors
• Amantadine
• Carbidopa-levodopa
• COMT Inhibitors
• Others
Global Parkinson's Disease Drug Market-Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• AbbVie Inc
• Apotex Inc
• Axovant Gene Therapies Ltd
• Boston Scientific Corp
• Cipla Inc
• Eisai Co Ltd
• Eli Lily & Co
• Impax Laboratories Inc
• Mylan NV
• Novartis International AG
• Pfizer Inc
• Sanofi SA
• Teva Pharmaceuticals Industries Ltd
• Wockhardt Ltd
• Orion Corp
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parkinson's Disease Drug Market Trends, Research Report, Growth, Opportunities, Forecast 2022-2028 here
News-ID: 2634298 • Views: …
More Releases from Orion Market Research
Payment Gateway Market | Business Growth, Development Factors, Current and Futur …
The global payment gateway market is anticipated to grow at a significant CAGR of 15.7% during the forecast period. The shifting financial services toward the cloud is the major factor driving the growth of the payment gateway market. Numerous banks across the globe are making efforts to enter into partnerships with payment gateway service providers to offer real-time payment facilities to consumers and merchants, without any physical contact. For instance,…
Facility Management Market | Business Growth, Development Factors, Current and F …
The global facility management market is growing at a considerable CAGR of 13.5% during the forecast period. The major factor that is augmenting the growth of the global facility management is an increase in demand for facility management solutions integrated with intelligent software. Moreover, growing changes in the structure of an organization along with work management and growing adoption of the Internet of Things (IoT) are also estimated to be…
Insight Engines Market | Business Growth, Development Factors, Current and Futur …
The global market for insight engines is projected to have a considerable CAGR of around 23.2% during the forecast period. The Insight engine is a platform with cognitive capabilities. Insight engines enable users to search, discover and analyse both structured and unstructured data. Employees and customers use these tools to quickly and easily find information and data, whether that be content, documents, or raw data. Insight engines can be used…
Non-Fungible Token Market | Business Growth, Development Factors, Current and Fu …
The global non-fungible token market is anticipated to grow at a considerable CAGR of 10.6% during the forecast period. The non-fungible token is unique in its form, and there cannot exist another like it. A non-fungible token is a type of cryptographic token that represents a unique identity. These token can be digital or physical and includes items like sneakers, art, a plane ticket, a university degree, real estate, and…
More Releases for Parkinson
QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency.
The firm recognised that to continue delivering high quality services to its clients it needed to provide…
Wolff Parkinson White syndrome Market found Future opportunities of 2023
The Analysis presents the study of Global Wolff Parkinson White syndrome Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold
Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Global…
PARKINSON RESEARCH FOUNDATION Announces Director of Patient Programs, Services a …
The Parkinson Research Foundation is pleased to announce that Marilyn Tait has joined the foundation as the Director of Patient Programs, Services and Advocacy. Tait, is a graduate of Thomas Jefferson University School of Nursing in Philadelphia, Pennsylvania. Tait has forty years experience in healthcare marketing and program development. After specializing in oncology for 30 years, Tait embarked on her new career at a time in her life when…
PARKINSON RESEARCH FOUNDATION’S (PRF) WESTERN CARIBBEAN FOURTH EDUCATIONAL CRU …
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field.
After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRF’s ventured to the Western Caribbean on its most…
PARKINSON RESEARCH FOUNDATION (PRF) Develops New Patient Outreach Program
One of the principal missions of the Parkinson Research Foundation (PRF) that distinguishes it from other Parkinson organizations is PRF’s focus on patient education; specifically education that enables Parkinson patients and their caregivers to live fuller and more comfortable lives with Parkinson's disease.
The Foundation’s educational events, including educational cruises, gather leading Parkinson experts, therapists and nutritionists from across the country to offer life-changing tools and knowledge for individuals affected…
Parkinson`s Disease:New Hope Educational Conference
PARKINSON’S DISEASE: NEW HOPE EDUCATIONAL CONFERENCE
Become knowledgeable about the advancements in surgery
The Parkinson Research Foundation is proud to announce that Dr. James Schumacher will be speaking about advances in surgery at our fourth annual New Hope for Parkinson’s conference on November 1st in Boca Raton. Dr. Schumacher is an internationally known expert in the field of neurosurgical treatment of Parkinson’s disease and movement disorders. He has an extensive background and…
